Scientists hunt for clues in blood and urine to personalize lung treatment

NCT ID NCT07254338

First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 13 times

Summary

This study looks at 80 people with lung fibrosis who also develop a serious lung blood pressure condition. Researchers will test blood and urine before and during treatment to find chemical markers that show who benefits and who doesn't. The goal is to better understand how the treatment works and to help doctors choose the right patients for it.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hôpital Cardiologique et Pneumologique Louis Pradel

    RECRUITING

    Bron, Rhone, 69500, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.